Maternal serum inhibin-A for predicting preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 4, 2011, Pages 595-599

  El Gharib, Mohamed Nabih ^a   Morad, Ma ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

birth weight; Inhibin A; prediction of preeclampsia; preeclampsia

Indexed keywords

INHIBIN A;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOGRAPHY; EGYPT; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; UNIVERSITY HOSPITAL; VENOUS BLOOD;

CASE-CONTROL STUDIES; FEMALE; HUMANS; INHIBINS; LIVER FUNCTION TESTS; MOTHERS; OSMOLAR CONCENTRATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROGNOSIS;

EID: 79952411378     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.511345     Document Type: Article

References (37)

1. Brown MA, Lindheimer MD, de Swiet M, Van Assche A and Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy:statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
2. Robert JM, Cooper DW. Pathogenesis and genetic of preeclampsia. Lancet 2005;357:53-56.
3. Salomon LJ, Benattar C, Audibert F. Severe preeclampsia is associated with high inhibin-A levels and abnormal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517-1522. (Pubitemid 38056417)
4. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799. (Pubitemid 40311367)
5. Watanabe N, Kamel S, Ohkubo A, Yamanaka M, Makino K, Tokudo K. Urinary protein as measured with pyrogallol redmolybdate complex, manually and in a Hitachi automated analyzer. Clin Chem 1986;32:1551-1554. (Pubitemid 17027779)
6. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan S, Baird DT, McNeilly AS. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994;40:717-723. (Pubitemid 24216620)
7. Petrie A, Sabin C. Medical statistics at a glance. 2nd ed. Malden, Mass. Oxford: Blackwell; 2005.
8. Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
9. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004;111:298-302. (Pubitemid 38446102)
10. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-192. (Pubitemid 36792143)
11. Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004;104:1367-1391. (Pubitemid 40458737)
12. Levine RJ, Maynard SE, Qian C, Lim KH, Lucinda J, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al. Circulating angiogenic factors and the risk of preeclampsia. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683. (Pubitemid 38364626)
13. Tjoa ML, Qudejans CBM, Van Vugt JMG, BlankensteinMA, Van Wijk J. Markers for pre-symptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy 2004;23:171-189. (Pubitemid 39096213)
14. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002;109:759-764. (Pubitemid 37329250)
15. Petraglia F, Sawchenko P, Lim ATW, Vale W. Localization, secretion and action of inhibin in human placenta. Science 1987;237:189-192.
16. Robertson DM, Foulds LM, Leversha L. Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun 1985;126:220-226. (Pubitemid 15126611)
17. Petraglia F, Calza' L, Garuti GC. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990;71:487-492.
18. Rabinovici J, Goldsmith PC, Librach CL. Localization and regulation of the activin-A dimer in human placental cells. J Clin Endocrinol Metab 1992;75:571-576.
19. Petraglia F, Anceschi MM, Calza' L. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993;77:542-548. (Pubitemid 23230072)
20. Petraglia F, Garg S, Florio P, Sadick M, Gallinelli A, Wong WL, Krummen L, Comitini G, Mather J, Woodruff TK. Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy. Endocr J 1993;1:323-327.
21. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro-C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997;12:1089-1093. (Pubitemid 27271776)
22. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Ellis PM, Aitken DA, Groome NP. Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997;82:218-222. (Pubitemid 27021300)
23. Luisi S, Battaglia C, Florio P, D'Ambrogio G, Taponeco F, Santuz M, Genazzani AR, Petraglia F. Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, maternal serum in early pregnancy. Placenta 1998;19:435-438. (Pubitemid 28327704)
24. Petraglia S, Luisi S, Benedetto C. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab 1997;82:2991-2995. (Pubitemid 27385661)
25. Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with Preeclampsia. BMJ 2000;107:795-797. (Pubitemid 30311918)
26. Salomon LJ, Benattar C, Audibert F, Fernandez H, Duyme M, Taieb J, Frydman R. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003;189:1517-1522. (Pubitemid 38056417)
27. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592-1594. (Pubitemid 40807500)
28. Roes EM, Gaytant MA, Thomas CMG, Raijmakers MTM, Zusterzeel PLM, Peters WHM, Steegers EAP. First trimester inhibin-A concentrations and later development of preeclampsia. Acta Obstet Gynecol Scand 2004;83:117. (Pubitemid 38121742)
29. D'anna R, Baviera G, Corrado F, Leonardi L, Buemi M, Jasonni VM. Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? Acta Obstet Gynecol Scand 2002;81:540-543. (Pubitemid 34628083)
30. Morpurgo PS, Cetin I, Borgato S, Cortelazzi D, Nobile- DeSantis MS, Vaghi I, Beck-Peccoz P. Circulating levels of inhibin A, inhibin B and activin A in normal and intrauterine growth restricted (IUGR) fetuses. Eur J Obstet Gynecol Reprod Biol 2004;117:38-44. (Pubitemid 39335860)
31. Itoh Y, Suzuki Y, Yamamoto T, Kojima K, Murakami I, Suzumor N. Increase in serum concentrations of inhibin in early onset preeclampsia with intrauterine growth restriction. J Obstet Gynecol Res 2006;32:80-85.
32. Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert- Messerlian G, Severi FM, Petraglia F. Preeclampsia with fetal growth restriction: placental and serum activin A levels. Gynecol Endocrinol 2002;16:365-372. (Pubitemid 35398650)
33. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;101:669-674. (Pubitemid 24251519)
34. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3-19. (Pubitemid 11240946)
35. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;60:365-372.
36. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991;12:301-308.
37. Kim SY, Ryu HM, Yang JH, Kim MY, Ahn HK, Shin JK, Choi JK, Park SY, Kim JM, Lee BY, Kim DJ. Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. J Korean Med Sci 2006;21:452-456.619-625